1. Home
  2. OMCL vs AORT Comparison

OMCL vs AORT Comparison

Compare OMCL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omnicell Inc. ($0.001 par value)

OMCL

Omnicell Inc. ($0.001 par value)

HOLD

Current Price

$46.27

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$40.25

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMCL
AORT
Founded
1992
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2001
1993

Fundamental Metrics

Financial Performance
Metric
OMCL
AORT
Price
$46.27
$40.25
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$51.50
$49.36
AVG Volume (30 Days)
525.2K
312.9K
Earning Date
02-05-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$1,177,740,000.00
$422,646,000.00
Revenue This Year
$8.61
$15.97
Revenue Next Year
$4.30
$10.96
P/E Ratio
$109.75
N/A
Revenue Growth
10.67
9.81
52 Week Low
$22.66
$21.97
52 Week High
$55.00
$48.25

Technical Indicators

Market Signals
Indicator
OMCL
AORT
Relative Strength Index (RSI) 41.58 32.25
Support Level $45.10 $39.50
Resistance Level $50.14 $41.97
Average True Range (ATR) 1.72 1.40
MACD -0.80 -0.19
Stochastic Oscillator 18.25 12.86

Price Performance

Historical Comparison
OMCL
AORT

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: